RE:RE:RE:RE:Increase of Options from 10% to 14% of outstanding SharesExactly. No increase should be forthcoming. The BOD has provided nothing but empty promises. Again, at the end of Oct Coffey said the next 6-8 months would be the most important and exciting in their existence. To me this suggests a culmination to the Onc story. The SP would suggest otherwise. If I were to guess, I would say a b/o isn't on the horizon, and may not ever happen. Maybe we get a BS biobucks deal, and the BOD is loading up to compensate for under-selling Onc. Wtv it is, Coffey appears to have no answer on how to create shareholder value.